Associated Papers
A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1.
Graillon T et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
38630553 (PubMed )
Supplement: ccr-23-3308_supplementary_table_s2_suppts2.xlsx › Feuil1
Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission Risk.
Chen JL et al.
Annual Review of Genomics and Human Genetics, 2022
36044908 (PubMed )
Supplement: gg23-giannikou_suptable1.xlsx › NF2
NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas.
Sakai Y et al.
Cancers, 2022
35804955 (PubMed )
Supplement: cancers-14-03183-s001.zip › supplementary_table_S4.xlsx › supplementary_table
High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma.
Raffeld M et al.
Acta Neuropathologica Communications, 2020
32641156 (PubMed )
Supplement: 40478_2020_973_MOESM2_ESM.xlsx › Sheet1
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis.
Boyd C et al.
Clinical Genetics, 2008
Exon scanning for mutation of the NF2 gene in schwannomas.
Jacoby LB et al.
Human Molecular Genetics, 1994
Select a paper to view details